Maria Tagliamonte

4PUBLICATIONS
23CO-AUTHORS
NanomedicineBiomaterialsInnate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Apr 14, 2022
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma.

Markus W Löffler, Stefania Gori, Francesco Izzo

|Feb 27, 2021
Identification and characterization of heteroclitic peptides in TCR-binding positions with improved HLA-binding efficacy.

Beatrice Cavalluzzo, Concetta Ragone, Angela Mauriello

|Feb 29, 2020
Exploiting Preexisting Immunity to Enhance Oncolytic Cancer Immunotherapy.

Siri Tähtinen, Sara Feola, Cristian Capasso

|Aug 05, 2019
Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders.

Laura Fantuzzi, Maria Tagliamonte, Maria Cristina Gauzzi

Pageof 1